We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current RDY market cap is 13.5B. The company's latest EPS is INR and P/E is N/A.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| INR (₨) | INR (₨) | INR (₨) | INR (₨) | INR (₨) | |
| Total Revenue | 62.97B | 66.14B | 70.04B | 72.15B | 70.83B |
| Operating Income | -33.94B | 17.61B | 17.6B | 17.4B | 14.83B |
| Net Income | 9.59B | 14.03B | 14.8B | 13.79B | 13.07B |
| Year End March 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| INR (₨) | INR (₨) | INR (₨) | INR (₨) | INR (₨) | |
| Total Revenue | 178.76B | 190.62B | 216.11B | 252.99B | 282.45B |
| Operating Income | 34.25B | 34.08B | 36.76B | 59.76B | 67.4B |
| Net Income | 20.26B | 19.52B | 21.83B | 45.07B | 55.78B |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| INR (₨) | INR (₨) | INR (₨) | INR (₨) | INR (₨) | |
| Total Assets | 321.85B | 335.04B | 347.02B | 0 | 387.52B |
| Total Liabilities | 90.86B | 89.78B | 93.94B | 0 | 106.97B |
| Total Equity | 230.99B | 245.26B | 253.09B | 0 | 280.55B |
| Year End March 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| INR (₨) | INR (₨) | INR (₨) | INR (₨) | INR (₨) | |
| Total Assets | 232.25B | 266.17B | 297.47B | 322.85B | 388.64B |
| Total Liabilities | 76.27B | 89.75B | 105.35B | 89.99B | 106.09B |
| Total Equity | 155.99B | 176.42B | 192.12B | 232.86B | 282.55B |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| INR (₨) | INR (₨) | INR (₨) | INR (₨) | INR (₨) | |
| Operating | 58.88B | 11.25B | 29.18B | N/A | 45.43B |
| Investing | -41.37B | -8.24B | -12.75B | N/A | -40.28B |
| Financing | -26.86B | -1.48B | -8.51B | N/A | -3.76B |
| Year End March 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| INR (₨) | INR (₨) | INR (₨) | INR (₨) | INR (₨) | |
| Operating | 29.84B | 35.7B | 28.11B | 58.88B | 45.43B |
| Investing | -4.92B | -22.66B | -26.39B | -41.37B | -40.28B |
| Financing | -25.16B | -298M | -2.42B | -26.86B | -3.76B |
| Market Cap | 13.5B |
| Price to Earnings Ratio | N/A |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 166.82M |
| Average Volume (1 week) | 194.03k |
| Average Volume (1 Month) | 257.63k |
| 52 Week Change | 22.47% |
| 52 Week High | 81.13 |
| 52 Week Low | 63.72 |
| Spread (Intraday) | 0.11 (0.14%) |
| Company Name | Dr Reddys Laboratories Ltd |
| Address |
8-2-337, road no. 3, banjara hills hyderabad, andhra pradesh 500034 |
| Website | https://www.drreddys.com |
| Industry | pharmaceutical diversified (H2) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
